Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research
Establishment of Normal Parameters for Blood and Sputum With Samples Obtained From Volunteers in Bamako
2 other identifiers
observational
253
1 country
1
Brief Summary
This study, conducted in Bamako, Mali (West Africa), will collect blood and sputum samples to establish normal values for laboratory test results among Malians. Researchers are starting a new initiative to study HIV and tuberculosis in Africa, using Mali as a model country. In order to perform these studies, the scientists need to know what constitutes normal laboratory values among the population. People in developing countries may have dramatically different laboratory values from those who live in developed countries, and there is currently little information available to distinguish normal from abnormal results in Malians. This study will establish normal ranges that will provide a basis for future HIV and tuberculosis research in Mali. Additionally it will provide blood and sputum samples to researchers to study different scientific questions related to HIV and Tuberculosis infection. Healthy volunteers and people infected with HIV or tuberculosis, or both, who are 18 years of age or older and who live in Bamako, Mali, may be eligible for this study. Candidates are screened with a medical history, physical examination, and blood test. Participants provide a blood or sputum sample, or both, for laboratory analysis. Blood is collected through a needle inserted into an arm vein, and sputum is collected by having the participant cough deeply and spit in a cup. Participants may agree to provide samples one time only or on a returning visit basis. Returning visits may be scheduled daily or weekly. Subjects may continue to participate for the duration of the 4-year study, provided their medical history and physical examination are updated once a year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2005
CompletedFirst Submitted
Initial submission to the registry
June 19, 2006
CompletedFirst Posted
Study publicly available on registry
June 21, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedApril 5, 2018
May 1, 2013
June 19, 2006
April 4, 2018
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Age 18 yrs or older.
- Adequate venous access.
- Willingness to allow blood samples to be stored and used for future studies of HIV infection and pathogenesis.
- Ability to sign informed consent and willingness to comply with study requirements and procedures.
You may not qualify if:
- Anemia (Hg less than10 g/dl) (for patients donating blood only).
- Underlying heart disease or bleeding disorder which in the judgment of the PI could increase the risk to the volunteer.
- Fever of 101 degrees F or evidence of an acute infection. (for patients donating blood only)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universite of Bamako
Bamako, Mali
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sophia B Siddiqui, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
June 19, 2006
First Posted
June 21, 2006
Study Start
January 4, 2005
Study Completion
May 1, 2013
Last Updated
April 5, 2018
Record last verified: 2013-05-01